sorbitan-monooleate and sorbitan-monolaurate

The present study was focused on investigating niosomal gels loaded with cholinergic drug; pilocarpine HCl, for prolonged precorneal residence time and improved bioavailability for glaucoma treatment. Pilocarpine HCl niosomes were prepared using various nonionic surfactants (span 20, span 60 and span 80), in the presence of cholesterol in different molar ratios by ether injection method. The selected formulations were incorporated into carbopol 934 and locust bean gum-based gels. TEM analysis confirmed that niosomes formed were spherical in shape and has a definite internal aqueous space with uniform particle size. Formulation F4 composed of span 60 and cholesterol (1:1) gave the highest entrapment (93.26 ± 1.75%) and slower release results after 8 hours (Q8h = 60.35 ± 1.87%) among other formulations. The

Topics: Administration, Ophthalmic; Animals; Chemistry, Pharmaceutical; Drug Delivery Systems; Drug Liberation; Drug Stability; Glaucoma; Hexoses; Intraocular Pressure; Liposomes; Particle Size; Pilocarpine; Rabbits

In the present work, we show that we obtained nanometric structures made of water, 1,2-dipalmitoyl-sn-glycero-3-phosphatidylcholine (DPPC), cholesterol (Chol), and a mixture of ethoxylated and non-ethoxylated sorbitan fatty acid esters (Tween 20, Span 20, Tween 80, and Span 80) by mixing all of them near the cloud point temperature (cp) of the ethoxylated surfactant. The influence that the constituents had on the size of the particle was determined by a pseudo-ternary phase diagram of water/Tween-Span/DPPC-Chol; the colloidal particles obtained were studied by differential scanning calorimetry, confocal fluorescence microscopy, scanning electron microscopy, and atomic force microscopy. These studies were made for all the systems with at least 23 d of colloidal stability. The most stable system was obtained with the Tween 80-Span 80 pair, behaving as a typical suspension for 48 d; this system was made of water, Tween 80-Span 80 (80:20), DPPC-Chol (95:5) in a corresponding molar ratio of 48:37:100:10. The colloidal particles obtained were a kind of emulsion and liposome structures. The second stable system was obtained with the same mixture, but in a molar ratio of 8:6:9:0, its structure was also a kind of emulsion particles. In both systems and in other less stable ones, the "emulsion particle" was completely new, it structurally corresponds to a nucleus of mixed micelles surrounded by at least one bilayer of DPPC.

Topics: 1,2-Dipalmitoylphosphatidylcholine; Cholesterol; Emulsions; Hexoses; Lipids; Liposomes; Molecular Structure; Particle Size; Polysorbates; Surface Properties; Water

Granisetron hydrochloride (granisetron) is a potent antiemetic that has been proven to be effective in acute and delayed emesis in cancer chemotherapy. Granisetron suffers from reduced oral bioavailability (≈60%) due to hepatic metabolism. In this study the combined advantage of provesicular carriers and buccal drug delivery has been explored aiming to sustain effect and improve bioavailability of granisetron via development of granisetron provesicular buccoadhesive tablets with suitable quality characteristics (hardness, drug content, in vitro release pattern, exvivo bioadhesion and in vivo bioadhesion behavior). Composition of the reconstituted niosomes from different prepared provesicular carriers regarding type of surfactant used and cholesterol concentration significantly affected both entrapment efficiency (%EE) and vesicle size. Span 80 proniosome-derived niosomes exhibited higher encapsulation efficiency and smaller particle size than those derived from span 20. Also, the effect of %EE and bioadhesive polymer type on in vitro drug release and in vivo performance of buccoadhesive tablets was investigated. Based on achievement of required in vitro release pattern (20-30% at 2h, 40-65% at 6h and 80-95% at 12h), in vivo swelling behavior, and in vivo adhesion time (>14 h) granisetron formulation (F19, 1.4 mg) comprising HPMC:carbopol 974P (7:3) and maltodextrin coated with the vesicular precursors span 80 and cholesterol (9:1) was chosen for in vivo study. In vivo pharmacokinetic study revealed higher bioavailability of buccal formulation relative to conventional oral formulation of granisetron (AUC0-∞ is 89.97 and 38.18 ng h/ml for buccal and oral formulation, respectively). A significantly lower and delayed Cmax (12.09±4.47 ng/ml, at 8h) was observed after buccal application compared to conventional oral tablet (31.66±10.15 ng/ml, at 0.5 h). The prepared provesicular buccoadhesive tablet of granisetron (F19) might help bypass hepatic first-pass metabolism and improve bioavailability of granisetron with the possibility of reducing reported daily dose (2mg) and reducing dosing frequency.

Topics: Adhesiveness; Administration, Buccal; Adult; Animals; Antiemetics; Biological Availability; Chemistry, Pharmaceutical; Chickens; Cholesterol; Granisetron; Hardness; Hexoses; Humans; In Vitro Techniques; Male; Mouth Mucosa; Polysaccharides; Rabbits; Tablets

Nicardipine hydrochloride has been used widely for the treatment of angina pectoris and hypertension. Because of its extensive first pass metabolism after oral administration, the transdermal administration of nicardipine microemulsions was developed in this study.. Microemulsions consisted of isopropyl myristate (IPM), surfactant mixture of Tween 80/Span 80 and/or Tween 80/Span 20, co-surfactant (ethanol) and aqueous phase. Pseudo-ternary phase diagrams were constructed using water titration method. The effect of component of microemulsion on the percutaneous absorption of drug was evaluated by in vitro permeation study.. The area of microemulsion isotropic region in the presence of ethanol was comparably larger in the absence of ethanol. The mean droplet size of nicardipine microemulsions ranged from 70 to 123 nm. With addition of ethanol, the droplet size became smaller. The permeation rate and extent of nicardipine microemulsion transport across rat skin was affected by the components of microemulsion. Nicardipine microemulsion had higher flux at surfactant mixture with lower hyrophile-lipophile balance (HLB) value and Tween content.. The microemulsion consisted of 52% IPM, 35% surfactant mixture and 13% water had higher permeation rate through rat skin above 122.53 ± 1.87 μg/cm2/h and was expected to develop a transdermal delivery system.

Topics: Adjuvants, Pharmaceutic; Administration, Cutaneous; Animals; Antihypertensive Agents; Drug Delivery Systems; Emulsions; Hexoses; In Vitro Techniques; Myristates; Nicardipine; Particle Size; Permeability; Polysorbates; Rats; Skin Absorption; Solubility; Surface-Active Agents; Vasodilator Agents

Niosomal vesicles are more stable than liposomal vesicles due to higher chemical stability of surfactants compared to phospholipids. Niosomes have been prepared from Span20, Span80, Tween20 and Tween80. Fluorescence resonance energy transfer studies have been performed in these systems to determine donor-acceptor distances. It has been found that the fluorescence resonance energy transfer efficiency is better in niosomes compared to micelles. The formation of niosomes is guided by the hydrophile-lipophile balance value of the nonionic surfactant.

Topics: Cholesterol; Fluorescence Resonance Energy Transfer; Hexoses; Light; Liposomes; Models, Chemical; Polysorbates; Scattering, Radiation; Spectrometry, Fluorescence; Surface-Active Agents

A defined change in formulation components affects the physical and chemical characteristics of cationic liposomes (CLs) carriers in many ways. Therefore, a great degree of control can be exercised over the structure by modifying the CLs with various materials, leading to new innovations for carrier improvement. In the present study, surface modifications of cationic liposomes with non-ionic surfactants--sorbitan monoesters serials (Span 85, 80, 40 and 20) were carried out for developing a new gene transfer carrier. Span modified cationic liposomes (Sp-CLs) were prepared by reverse phase evaporation method (RPV) and self-assemble complexes of antisense oligonucleotides/surfactant modifying cationic liposomes were prepared by auto-coacervation through electrostatic effect. Characterization of Sp-CLs and the self-assembled complex was performed by electron microscope, particle size, zeta potential, turbidity and agarose electrophoresis. Furthermore, in vitro cellular uptake experiment showed that Span plays a role in enhancing the cellular uptake of encapsulated oligonucleotides mediated by Sp-CLs by the endocytosis-dependent route. CLs modified with Span 40 significantly facilitated the cellular uptake by COS-7 cells and HeLa cells; also showed some positive effect on gene expression. That suggests it is a potential non-viral carrier for efficient gene transfer.

Topics: Cations; Cell Line; Gene Transfer Techniques; Genetic Vectors; Green Fluorescent Proteins; HeLa Cells; Hexoses; Humans; Liposomes; Microscopy, Electron, Transmission; Nephelometry and Turbidimetry; Surface-Active Agents

The aim of this work was to investigate the role of HLB of emulsifier as well as volume of the internal aqueous phase (W(1)) and presence of salt in the external aqueous phase (W(2)) on the morphology, size and encapsulation efficiency of poly(D,L-lactide) microspheres containing naltrexone HCl. PLA microparticles containing naltrexone HCl, an effective opiate antagonist, were prepared by a water-in-oil-in-water emulsification-solvent evaporation procedure. One of the five different emulsifiers: span 80, span 20, tween 85, tween 80 and tween 20, with HLB values from 4-17 were added to W(1). Presence of emulsifier in W(1) resulted in smaller particles with a more dense and uniform internal structure. Incorporation of span 80 (HLB 4.3, suitable for W/O emulsions) yield the highest encapsulation efficiency. Increasing the HLB value to 8 or 11 (span 20 or tween 85) decreased the efficiency of naltrexone HCl-loading. HLB values higher than 15 (tween 80 or tween 20) increased encapsulation efficiency unexpectedly, which could be attributed to migration of these emulsifiers to the O/W(2) interface and modifying the surface properties of microparticles. Increasing the internal water phase volume from 0.2-1.8 ml resulted in larger particle size with poor encapsulation efficiency. Addition of 10% w/w NaCl to the W(2) changed the surface morphology of microspheres from a porous form to a smooth surface. It was shown that, by selecting the appropriate HLB value of emulsifier in W(1), addition of salt to W(2) and controlling the volume of W(1), one can control the encapsulation efficiency, size and morphology of microspheres.

Topics: Absorption; Drug Compounding; Emulsifying Agents; Hexoses; Microscopy, Electron, Scanning; Microspheres; Naltrexone; Narcotic Antagonists; Particle Size; Polyesters; Sodium Chloride; Surface-Active Agents

Creams from three components, surfactant, purified water and oil, were prepared. Comparable molar fractions of components were used in order to better understand the structural properties of the components used. The surfactants were sorbitan monoesters, sorbitan monolaurate, monopalmitate, monostearate and monooleate, which differed from each other in the length or structure of the hydrocarbon chain. The oils used were isopropylpalmitate and myristate, and they differed from each other in the length of the fatty acid chain. Rheological properties, droplet size distributions and types (either o/w or w/o) of the creams were studied. The rheological tests used were oscillation stress sweep test, creep recovery test and viscosity test. The modelling of the creep phase was based on the creep recovery test. Sorbitan monolaurate and monostearate formed w/o creams, sorbitan monopalmitate and monooleate o/w creams. It appeared that the double-bonded structure of the surfactant made the cream less elastic. Elasticity was increased due to lengthening of the alkyl chain of the surfactant and increased amount of surfactant. Also the lengthening of the fatty acid chain of the oil made the creams more elastic. The results of the rheological tests and droplet size distributions correlated well each other. According to the modelling of the creep phase, creams could be represented either with the Burger model or with the Maxwell model.

Topics: Elasticity; Hexoses; Ointments; Rheology; Surface-Active Agents

Using the analytical constants for sorbitan monolaurate, monopalmitate, monostearate, and monooleate given in the National Formulary (NF), calculations were carried out that indicated that these emulsifiers are esters of sorbitol mono- and dianhydrides. Contrary to the NF description, no significant amount of sorbitol ester was calculated to be present, in agreement with recent experimental findings. Further calculations were made using the NF-defined analytical constants of polysorbate 20, polysorbate 40, polysorbate 60, and polysorbate 80, which indicate that these emulsifiers are esters primarily of polyoxyethylated sorbitol monoanhydride (i.e., sorbitan), with lesser quantities of polyoxyethylated esters of sorbitol dianhydride. Since all hydroxyl groups of the polysorbates are primary, random distribution of acyl groups on the available hydroxyls can be assumed, and the likely composition of these emulsifiers can be calculated. The most abundant compounds appear to be polyoxyethylated sorbitan mono-, di-, and triesters. Although the polysorbates are stated to contain 20 moles of ethylene oxide per mole of ester, the oxyethylene contents stated in the Food Chemicals Codex reveal that somewhat more than 20 moles of ethylene oxide are combined.

Topics: Chemistry, Pharmaceutical; Excipients; Hexoses; Pharmacopoeias as Topic; Polysorbates; United States